PubMed · 2012 · 23 citations · 25 references
MedicineNeurosciencePharmacologyInflammationNeuroimmunologyNeuropharmacologyAcute Ischemic StrokeCerebrovascular DiseaseNeuroprotectionNeuroprotective PharmacologyStrokeCerebral InjuryCerebral Ischemia NeuroprotectionCerebral Ischemia PharmacotherapyMotor Neuron FunctionNeuroprotective AgentsNeuroprotective MechanismsNeuroprotective ResponsesRodent Cerebral Ischemia
Anti-inflammatory and anti-oxidant agents can alleviate ischemic cerebral injury. The immunomodulary drug Setarud, which is composed of herbal extracts including Rosa canina, Urtica dioica and Tanacetum vulgare, supplemented with selenium exhibits anti-inflammatory and anti-oxidant properties. Therefore, we hypothesized that Setarud will have a neuroprotective effect against ischemic cerebral injury. To validate this hypothesis, rats were intraperitoneally administered with 0.66 mL/kg Setarud for 30 minutes after middle cerebral artery occlusion. Triphenyltetrazolium chloride staining showed that Setarud could reduce cerebral infarct volume of rats subjected to cerebral ischemia. Transmission electron microscopy and hematoxylin-eosin staining results showed that Setarud could alleviate the degenerative changes in cortical neurons of rats with cerebral ischemia. The inclined plate test and prehensile test showed that Setarud could significantly improve the motor function of rats with cerebral ischemia. These findings suggest that Setarud shows neuroprotective effects against ischemic brain injury.
25
Reversible middle cerebral artery occlusion without craniectomy in rats.
Enrique Zea Longa, Philip R. Weinstein, Shaun W. Carlson et al. · Stroke · 1989 · 7.5K citations · Full text
Medicine, Neuroscience, Surgery +17
Occlusive disease of the middle cerebral artery
Louis R. Caplan, Viken L. Babikian, Cathy M. Helgason et al. · Neurology · 1985 · 169 citations
Medicine, Neurology, Neuroscience +17
Carmelina Gemma, Michael H. Mesches, Boris Sepesi et al. · Journal of Neuroscience · 2002 · 143 citations · Full text